Skip to Content

UK Edition. Click here for US version.


PDF options:  View Fullscreen   Download PDF

PDF Transcript

(olmesartan medoxomil)
This medicine is known by any of the above names but will be referred to as Olmetec throughout this leaflet.
Please note that the leaflet also contains information about other strengths (Olmetec 20mg film-coated
Tablets, Olmetec 40mg film-coated Tablets).
Read all of this leaflet carefully before you start taking this medicine because it contains important
information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Olmetec is and what it is used for
2. What you need to know before you take Olmetec
3. How to take Olmetec
4. Possible side effects
5. How to store Olmetec
6. Contents of the pack and other information
Olmetec belongs to a group of medicines called angiotensin-II receptor antagonists. They lower blood
pressure by relaxing the blood vessels.
Olmetec is used for the treatment of high blood pressure (also known as ‘hypertension’) in adults and in
children and adolescents aged 6 to less than 18 years. High blood pressure can damage blood vessels in
organs such as the heart, kidneys, brain and eyes. In some cases this may lead to a heart attack, heart or
kidney failure, stroke or blindness. Usually high blood pressure has no symptoms. It is important to have
your blood pressure checked to prevent damage occurring.
High blood pressure can be controlled with medicines such as Olmetec tablets. Your doctor has probably
also recommended that you make some changes in your lifestyle to help lower your blood pressure (for
example losing weight, giving up smoking, reducing the amount of alcohol you drink and reducing the
amount of salt in your diet). Your doctor may also have urged you to take regular exercise, such as walking
or swimming. It is important to follow this advice from your doctor.
Do not take Olmetec:
• if you are allergic to olmesartan medoxomil or any of the other ingredients of this medicine (listed in
section 6).
• if you are more than 3 months pregnant. (It is also better to avoid Olmetec tablets in early pregnancy see pregnancy section.)
• if you suffer from yellowing of the skin and eyes (jaundice) or problems with drainage of the bile from the
gallbladder (biliary obstruction e.g. gallstones).
• if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering
medicine containing aliskiren.
Warnings and precautions
Talk to your doctor before using Olmetec. Tell your doctor if you are using any of the following medicines
used to treat high blood pressure:
• an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related
kidney problems.
• aliskiren
Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g.
potassium) in your blood at regular intervals. See also information under the heading “Do not take Olmetec”.
Tell your doctor if you have any of the following health problems:
• Kidney problems
• Liver disease
• Heart failure or problems with your heart valves or heart muscle
• Severe vomiting, diarrhoea, treatment with high doses of water tablets (diuretics) or if you are on a low
salt diet
• Increased levels of potassium in your blood
• Problems with your adrenal glands.
Contact your doctor if you experience diarrhoea that is severe, persistent and causes substantial weight
loss. Your doctor may evaluate your symptoms and decide on how to continue your blood pressure
As with any medicine which reduces blood pressure, an excessive drop in blood pressure in patients with
blood flow disturbances of the heart or brain could lead to a heart attack or stroke. Your doctor will therefore
check your blood pressure carefully.
You must tell your doctor if you think you are (or might become) pregnant. Olmetec is not recommended in
early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious
harm to your baby if used at that stage (see pregnancy section).
Black patients
As with other similar drugs the blood pressure lowering effect of Olmetec is somewhat less in black patients.
Elderly people
If you are 65 years or over and your doctor decides to increase your dose of olmesartan medoxomil to 40
mg daily, then you need to have your blood pressure regularly checked by your doctor to make sure that
your blood pressure does not become too low.
Children and adolescents
Olmetec has been studied in children and adolescents. For more information, talk to your doctor. Olmetec is
not recommended for children from 1 year to less than 6 years and should not be used in children under the
age of 1 year as no experience is available.
Other medicines and Olmetec:
Tell your doctor or pharmacist if you are using have recently used or might use any other medicines.
In particular, tell your doctor or pharmacist about any of the following:
• Other blood pressure lowering medicines, as the effect of Olmetec can be increased.
Your doctor may need to change your dose and/or to take other precautions:
If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take
Olmetec” and “Warnings and precautions”).
• Potassium supplements, a salt substitute which contains potassium, water tablets (diuretics) or heparin
(for thinning the blood). Using these medicines at the same time as Olmetec may raise the levels of
potassium in your blood.
• Lithium (a medicine used to treat mood swings and some types of depression) used at the same time as
Olmetec may increase the toxicity of lithium. If you have to take lithium, your doctor will measure your
lithium blood levels.
• Non-Steroidal Anti-Inflammatory (NSAIDs) medicines (medicines used to relieve pain, swelling and other
symptoms of inflammation, including arthritis) used at the same time as Olmetec may increase the risk of
kidney failure and the effect of Olmetec can be decreased by NSAIDs.
• Colesevelam hydrochloride, a drug that lowers the level of cholesterol in your blood, as the effect of
Olmetec may be decreased. Your doctor may advise you to take Olmetec at least 4 hours before
colesevelam hydrochloride.
• Certain antacids (indigestion remedies), as the effect of Olmetec can be slightly decreased.
Olmetec with food and drink
Olmetec can be taken with or without food.
Pregnancy and breast-feeding
You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise
you to stop taking Olmetec before you become pregnant or as soon as you know you are pregnant and will
advise you to take another medicine instead of Olmetec. Olmetec is not recommended in early pregnancy,
and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if
used after the third month of pregnancy.

Tell your doctor if you are breast-feeding or about to start breast-feeding. Olmetec is not recommended for
mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to
breast-feed, especially if your baby is newborn, or was born prematurely.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or
pharmacist for advice before taking this medicine.

Driving and using machines
You may feel sleepy or dizzy while being treated for your high blood pressure. If this happens, do not drive
or use machines until the symptoms wear off. Ask your doctor for advice.
Olmetec contains lactose monohydrate
This medicine contains lactose monohydrate (a type of sugar).
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor
before taking this medicinal product.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you
are not sure.
The recommended starting dose is one 10 mg tablet once a day. However, if your blood pressure is not
controlled, your doctor may decide to change your dose up to 20 or 40 mg once a day, or prescribe
additional medicines.
In patients with mild to moderate kidney disease, your dose will not be higher than 20 mg once a day.
The tablets can be taken with or without food. Swallow the tablets with a sufficient amount of water (e.g. one
glass). If possible, take your daily dose at the same time each day, for example at breakfast time.
Children and adolescents from 6 to less than 18 years of age:
The recommended starting dose is 10 mg once daily. If the patient’s blood pressure is not adequately
controlled, the doctor may decide to change the dose up to 20 or 40 mg once a day. In children who weigh
less than 35 kg, the dose will not be higher than 20 mg once a day.
If you take more Olmetec than you should
If you take more tablets than you should or if a child accidentally swallows some, go to your doctor or
nearest emergency department immediately and take your medicine pack with you.
If you forget to take Olmetec
If you forget a dose, take your normal dose on the following day as usual. Do not take a double dose to
make up for a forgotten tablet.
If you stop taking Olmetec
It is important to continue to take Olmetec unless your doctor tells you to stop.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If they do occur,
they are often mild and do not require treatment to be stopped.
Although not many people may get them, the following two side effects can be serious:
On rare occasions (may affect up to 1 in 1,000 people) the following allergic reactions that may affect the
whole body have been reported:
Swelling of the face, mouth and/or larynx (voice box) together with itching and rash may occur during
treatment with Olmetec. If this happens stop taking Olmetec and contact your doctor immediately.
Rarely (but slightly more often in elderly people) Olmetec can cause the blood pressure to fall too low in
susceptible individuals or as the result of an allergic reaction. This could cause severe light-headedness or
fainting. If this occurs stop taking Olmetec, contact your doctor immediately and lie down flat.
These are the other side effects known about so far with Olmetec
Common side effects (may affect up to 1 in 10 people):
Dizziness, headache, nausea, indigestion, diarrhoea, stomach ache, gastroenteritis, tiredness, sore throat,
runny or stuffy nose, bronchitis, flu-like symptoms, cough, pain, pain in the chest, back, bones or joints,
infection of the urinary tract, swelling of ankles, feet, legs, hands or arms, blood in the urine.
Some changes in blood test results have also been seen and include the following:
Increased fat levels (hypertriglyceridaemia), increased uric acid levels (hyperuricaemia), rise in blood urea,
increases in tests of liver and muscle function.
Uncommon side effects (may affect up to 1 in 100 people):
Quick allergic reactions that may affect the whole body and may cause breathing problems as well as a
rapid fall of blood pressure that may even lead to fainting (anaphylactic reactions), swelling of the face,
vertigo, vomiting, weakness, feeling unwell, muscular pain, skin rash, allergic skin rash, itching, exanthema
(skin eruption), skin lumps (wheals), angina (pain or uncomfortable feeling in the chest).
In blood tests a reduction of the numbers of a type of blood cell, known as platelets has been seen
Rare side effects (may affect up to 1 in 1,000 people):
Lack of energy, muscle cramps, impaired kidney function, kidney failure.
Some changes in blood test results have also been seen. These include increased potassium levels
(hyperkalaemia) and increased levels of compounds related to kidney function.
Additional side effects in children and adolescents:
In children, side effects are similar to those reported in adults. However, dizziness and headache are seen
more often in children, and nose bleeding is a common side effect seen in children only.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: or search for MHRA Yellow Card in the Google Play or Apple App Store. By
reporting side effects, you can help provide more information on the safety of this medicine.
• Keep out of the sight and reach of children.
• There are no special storage instructions for Olmetec.
• Do not use the medicine after the expiry dated printed on the carton label or blister strip. The expiry date
refers to the last day of that month.
• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to
dispose of medicines no longer required. These measures will help to protect the environment.
• If the tablets become discoloured or show any other signs of deterioration, consult your pharmacist who
will tell you what to do.
Olmetec 10mg Film-coated Tablets: Each film-coated tablet contains 10mg of the active ingredient
olmesartan medoxomil. The tablets are white, circular, film-coated with ‘C13’ embossed on one side.
Olmetec also contains the following inactive ingredients:
hydroxypropylcellulose, magnesium stearate, titanium dioxide (E171), talc and hypromellose.


Olmetec is available in blister packs of 30 and 90 tablets.
PL No: 17805/0249
Olmetec® 10mg film-coated Tablets/ Olmesartan medoxomil 10mg film-coated Tablets
This product is manufactured by Daiichi Sankyo Europe GmbH, Luitpoldstrasse 1, 85276 Pfaffenhofen,
Germany and procured from within the EU by the Product Licence holder Delta Pharma (Europe) Ltd., 1
Colonial Way, P.O. Box 233, North Watford, Herts WD24 4EW and repackaged by O.P.D. Laboratories Ltd.,
Watford, Herts WD24 4PR.
Olmetec is a registered trademark of Daiichi Sankyo Company Limited, Japan.
Leaflet revision date (ref): 11.10.2017.

To request a copy of this leaflet in Braille, large print or
audio please call 01923 332 796.

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.